-
2 weeks ago | 
informaconnect.com | Brandy Fidler
Proactive compliance within reimbursement hubs, strategic navigation of data purchases, and medical and commercial interactions are among the rising trends in pharmaceutical compliance this year. In a recent webinar, “Pharmaceutical Compliance: Emerging Trends & Best Practices for 2025” webinar, hosted by the Pharmaceutical Compliance Congress in March, a group of compliance experts discussed the latest movements in the industry, offering insights and strategies to implement.
-
2 weeks ago | 
informaconnect.com | Brandy Fidler
Doreen Rice, director of patient assistance programs at AstraZeneca, shared her experience working strategically with legal and compliance teams at the recent Access USA conference.
-
2 weeks ago | 
informaconnect.com | Brandy Fidler
Compliance expert agrees that artificial intelligence (AI) can enhance compliance functions, but it will require careful implementation and human oversight to realize its full potential.
-
2 weeks ago | 
informaconnect.com | Brandy Fidler
In an exclusive interview with Compliance Insider, Brian Sharkey, head of US compliance and ethics at Teva Pharmaceuticals, discussed compliance challenges, strategies for addressing potential risks, and key performance metrics in compliance programs. Sharkey leads Teva’s compliance efforts across all US business units, including innovative medicines, biosimilars, and generics, as well as for subgroups such as sales, marketing, and market access.
-
3 weeks ago | 
informaconnect.com | Brandy Fidler
Katie Wilson, managing principal, patient support services, at IQVIA, discussed how the company is leveraging AI within its patient relationship management (PRM) software to improve patient experience.
-
3 weeks ago | 
informaconnect.com | Brandy Fidler
Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with Access Insider about how the UK’s National Institute for Health and Care Excellence (NICE) is spearheading a global shift in pharmaceutical decision-making by incorporating health equity considerations into drug submissions. NICE provides guidance and evidence-based recommendations on emerging treatments and technologies for the National Health Service (NHS).
-
1 month ago | 
informaconnect.com | Brandy Fidler
Study finds patients initiating oral oncolytic therapy for chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) through an integrated health system specialty pharmacy (IHSSP) demonstrated high adherence and persistence to therapy.
-
1 month ago | 
informaconnect.com | Brandy Fidler
Welcome to Compliance Insider, a new monthly newsletter designed to keep you informed on the topics and trends of pharmaceutical compliance, including regulatory, risk mitigation, and effective compliance programs. Inspired by our Compliance & Legal events community, we plan to give our readers and compliance and legal professionals a newsletter that provides them with insights, original thought-leadership interviews, and news articles that could benefit their compliance strategy in return.
-
1 month ago | 
informaconnect.com | Brandy Fidler
Integrated specialty pharmacies are gaining traction, particularly medically integrated specialty pharmacies (MIPs), due to enhanced patient outcomes and demonstrated value, according to Karen Thomas, associate director, specialty and infusion pharmacies and clinical assistant professor at the University of Illinois Chicago.
-
1 month ago | 
informaconnect.com | Brandy Fidler
Compliance experts talk about trending business models, including early engagement and the need to do more with less. Pharma companies have been increasingly focused on pre-PDUFA (Prescription Drug User Fee Act) market development, according to Darren Jones, partner at Baker Tilly. He said, “I think as an industry, we always struggle with what can we engage with pre-PDUFA? What is the right level of market engagement?
